11-17 April 2012
Оценка профилактики и борьбы с туберкулезом и противотуберкулезной помощи в Азербайджане
11–17 апреля 2012 г.
Geneva, Switzerland 9th March 2016
Pessoas privadas de liberdade, por exemplo, detentos em presídios e outros locais de detenção, podem estar mais vulneráveis a doença do coronavírus (COVID-19) quando comparadas à população em geral, devido às condições de confinamento em que vivem com outras pessoas por períodos prolong...ados. Além disso, a experiência mostra que prisões, cadeias e locais semelhantes onde as pessoas estejam reunidas próximas entre si podem agir como fonte de infecção, amplificação e propagação de doenças infecciosas dentro e fora das prisões.
more
Strengthening supply chains to meet the growing demand for family planning will require systems diagnostics, supply chain redesign or adjustments, strategically located storage and distribution systems, adequate staffing and training, and better information about inventory and financing.
В настоящем документе проводится анализ международного права по проблематике прав человека с целью обеспечить законодателей, разработчиков политики, специалист...в, работающих в сфере охраны психического здоровья, и активистов неправительственных организаций информацией об обязанностях государств, которые должны быть отражены во внутреннем законодательстве по охране психического здоровья и правам инвалидов. В документе рассматриваются некоторые важнейшие права, базирующиеся на конвенциях, и стандарты Организации Объединенных Наций по правам человека, такие как Принципы ПБ и Стандартные правила. В документе показано, как эти стандарты можно использовать в качестве руководства по обеспечению соблюдения требований международных конвенций о правах человека.
more
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
Q9: For carers of people with dementia, do interventions (psychoeducational, cognitive-behavioural therapy counseling/case management, general support, training of caregivers, multi-component interventions and miscellaneous interventions) when compared to placebo/comparator, produce benefits/harm in... the specified outcomes?
more
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?
The plan outlines emergency health, WASH and communications interventions to contain and prevent further spread of the outbreak in the 227 high risk districts, where suspected cholera cases were reported during the period October 2016 to May 2017. Health and WASH clusters will continually identify p...riority districts from at
high risk districts, by considering the number of caseload and attack rate. As of 15 May, 30 priority high risk districts (10 Governorates) that report over 100 or more suspected cholera cases have been identified.
more
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
İŞBİRLİĞİ ODAKLI MÜDAHALELERE DAYALI UYGULANABİLİR YAKLAŞIMLAR
World Health Organization (2013)
Kırmızı Şemsiye Cinsel Sağlık ve İnsan Hakları Derneği (2017)
Q6: Can dementia be diagnosed at first or second level care by non-specialist health care providers? What should be the assessment process for the diagnosis of dementia?
Q10: Are antidepressants (Tricyclic antidepressants (TCA), Selective serotonin reuptake inhibitors (SSRIs)) effective and safe in children 6-12 years of age with depressive episode/disorder?
Q2: For people with dementia, does memantine, when compared to placebo/comparator, produce benefits/harm in the specified outcomes in non-specialist health settings?
Q 7: For adults and children with convulsive epilepsy, which standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) when compared to placebo/a comparator produce benefits/harm in the specified outcomes?